Medicinova, Inc
MediciNova, Inc.(NASDAQ: MNOV, TSE: 4875) is a late-stage, global biopharmaceutical company that is developing novel therapeutics with a primary focus on neurodegenerative disorders, beginning with Amyotrophic Lateral Sclerosis (ALS), with a secondary focus on conditions like respiratory and liver disease, fibrotic diseases, acute lung injury, metabolic diseases, and more with high unmet need. MediciNova’s goal is to address the unmet needs many patients are dealing with in these spaces, providing solutions and treatments to further address them while improving quality of life.
7-day free trial · no credit card
Verified contacts
9
available on Kipplo
LinkedIn employees
15
11 to 50 range
Open roles
—
no listings
Distinct roles
8
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 9 verified contacts at Medicinova, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
9 contacts with verified email or phone · masked until revealed.
- MM
Malath Makhay Bozym
Director, Research & Development · Science
EmailPhone - MM
Mark Munsey
Clinical Project Manager · Operations
EmailPhone - KS
Kiyomi Suzue
Accountant · Finance & Accounting
EmailPhone
Showing 3 of 9 verified contacts
Top roles at Medicinova, Inc
8 distinct titles indexed · top 8 shown.
- 1accountant
- 1bpo
- 1clinical director
- 1clinical project manager
- 1clinical trial specialist drug supply manager
- 1director, research & development
- 1senior clinical project manager
- 1treasurer board of directors
Sign up to unlock all 9 contacts at Medicinova, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 9 verified contacts at Medicinova, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.